| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jinming Han | Q85955987 |
| P2093 | author name string | Jie Zhu | |
| Xinmei Jiang | |||
| Xueli Fan | |||
| Tao Jin | |||
| Chenhong Lin | |||
| P2860 | cites work | Myasthenia gravis | Q72436386 |
| The germinal center response is impaired in the absence of T cell-expressed CXCR5 | Q79435564 | ||
| Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression | Q79769520 | ||
| CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo' | Q80796763 | ||
| Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia | Q83179551 | ||
| Blood relatives of follicular helper T cells | Q83312173 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes | Q84339471 | ||
| Association of circulating follicular helper T cells with disease course of NMO spectrum disorders | Q86174352 | ||
| Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma | Q87274147 | ||
| Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 | ||
| The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis | Q24308609 | ||
| Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages | Q24642180 | ||
| Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production | Q24676570 | ||
| Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation | Q28252247 | ||
| Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration | Q28253885 | ||
| A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage | Q28287540 | ||
| Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6 | Q28288702 | ||
| Multiple sclerosis | Q28299151 | ||
| Follicular helper CD4 T cells (TFH) | Q29615063 | ||
| A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis | Q29615952 | ||
| Regulatory T cells: mechanisms of differentiation and function | Q29620731 | ||
| T follicular helper cell dynamics in germinal centers | Q30573316 | ||
| Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. | Q30577078 | ||
| Neuromyelitis optica: an overview | Q33541803 | ||
| IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses | Q33656146 | ||
| PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells | Q33866996 | ||
| Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. | Q33988247 | ||
| Myasthenia gravis: an update for the clinician | Q34377145 | ||
| Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. | Q34377212 | ||
| Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells | Q34383385 | ||
| The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo | Q34440540 | ||
| Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus | Q34532672 | ||
| IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain | Q34548098 | ||
| Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression | Q34613311 | ||
| Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion | Q34615273 | ||
| Follicular helper T Cells (Tfh) and IL-21 involvement in the pathogenesis of bullous pemphigoid | Q34826941 | ||
| Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis | Q35101760 | ||
| The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. | Q50499734 | ||
| The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. | Q50736370 | ||
| Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. | Q50944222 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. | Q51278070 | ||
| Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. | Q51985886 | ||
| Cortactin autoantibodies in myasthenia gravis. | Q54324670 | ||
| RGMA and IL21R show association with experimental inflammation and multiple sclerosis | Q57224463 | ||
| The Ex Vivo Production of IL-6 and IL-21 by CD4+ T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients | Q59614759 | ||
| Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus | Q61411628 | ||
| Immunopathogenesis of neuromyelitis optica | Q38175587 | ||
| Diagnosis and classification of neuromyelitis optica (Devic's syndrome). | Q38178483 | ||
| Diagnostic and clinical classification of autoimmune myasthenia gravis. | Q38188287 | ||
| Bcl-6 controlled TFH polarization and memory: the known unknowns | Q38192415 | ||
| B cells in MS and NMO: pathogenesis and therapy | Q38212081 | ||
| Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches | Q38223709 | ||
| Neuromyelitis optica spectrum disorders. | Q38229823 | ||
| T follicular helper cell differentiation, function, and roles in disease | Q38264816 | ||
| Blood Tfh cells come with colors | Q38916112 | ||
| In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. | Q41949877 | ||
| Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. | Q42261388 | ||
| RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice | Q43656574 | ||
| The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands | Q44675588 | ||
| Higher frequency of peripheral blood interleukin 21 positive follicular helper T cells in patients with ankylosing spondylitis | Q45099346 | ||
| Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. | Q46006953 | ||
| Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients | Q46743437 | ||
| Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome | Q46884492 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers | Q47877284 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis | Q35978986 | ||
| The origins, function, and regulation of T follicular helper cells | Q36118326 | ||
| Follicular B helper T cells in antibody responses and autoimmunity. | Q36302329 | ||
| T follicular helper cell diversity and plasticity | Q36823844 | ||
| Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies | Q36911907 | ||
| T follicular helper (TFH) cells in normal and dysregulated immune responses | Q37049341 | ||
| SAP-controlled T-B cell interactions underlie germinal centre formation | Q37119530 | ||
| Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets | Q37436035 | ||
| Type 17 T helper cells-origins, features and possible roles in rheumatic disease | Q37478061 | ||
| Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection | Q37548026 | ||
| CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions | Q37646434 | ||
| AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance | Q37773790 | ||
| T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q37777431 | ||
| The elusive identity of T follicular helper cells | Q37784588 | ||
| A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis | Q37818921 | ||
| Follicular helper T cells poise immune responses to the development of autoimmune pathology | Q37822013 | ||
| Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. | Q37845414 | ||
| The regulation and role of T follicular helper cells in immunity | Q37951500 | ||
| Myasthenia and the neuromuscular junction | Q38034658 | ||
| Autoimmune mechanisms in myasthenia gravis. | Q38039921 | ||
| Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity. | Q38057541 | ||
| Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. | Q38093711 | ||
| Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis | Q38093885 | ||
| Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models | Q38105052 | ||
| The good, the bad and the ugly - TFH cells in human health and disease | Q38107389 | ||
| Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells | Q38108059 | ||
| The unique features of follicular T cell subsets | Q38121496 | ||
| Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation | Q38133301 | ||
| Priming of T follicular helper cells by dendritic cells | Q38154469 | ||
| Follicular T-helper cells: controlled localization and cellular interactions | Q38154470 | ||
| Human T follicular helper (Tfh) cells and disease | Q38154471 | ||
| Control of TFH cell numbers: why and how? | Q38159861 | ||
| Follicular helper T-cell memory: establishing new frontiers during antibody response | Q38159862 | ||
| Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis. | Q38161532 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| cell | Q7868 | ||
| autoimmune disease of the nervous system | Q18556300 | ||
| hemic and immune systems | Q70202933 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 638968 | |
| P577 | publication date | 2015-08-02 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Follicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal Models | |
| P478 | volume | 2015 |
| Q64044796 | Advances in autoimmune myasthenia gravis management |
| Q39085433 | Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications |
| Q26749131 | Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models |
| Q37667437 | Follicular T Cells from smB- Common Variable Immunodeficiency Patients Are Skewed Toward a Th1 Phenotype |
| Q55236740 | Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives. |
| Q64072217 | Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation |
| Q33784969 | Regulatory T cells in multiple sclerosis and myasthenia gravis. |
| Q55396042 | Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment. |
| Q55287599 | The Cerebellum of Patients with Steatohepatitis Shows Lymphocyte Infiltration, Microglial Activation and Loss of Purkinje and Granular Neurons. |
| Q90426166 | Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder |
Search more.